In addition, a decreased expression of one NKG2D ligand on HCC tumors, low neutrophil-lymphocyte blood ratios and tumor-associated macrophage counts have also been associated with HCC recurrence [9]–[12]. This evidence concerns the gene KLRK1 and hepatocellular carcinoma.